S

SHPG

Shire

This stock has been delisted.
News
Press Releases
Financial Reports
Profile
    Same Industry
    Name/Symbol
    Change%
    Price

    S

    Shire

    SHPG

    --
    179.20

    M

    McKesson

    MCK

    +0.95%
    695.00

    B

    Biogen Inc

    BIIB

    -0.56%
    118.84

    A

    Amgen Inc

    AMGN

    +0.36%
    280.84

    B

    Bristol-Myers Squibb Company Celegne Contingent Value Rights

    CELG-RT

    -1.69%
    0.0290

    C

    Celgene

    CELG

    --
    108.24

    L

    Lilly Eli & Co

    LLY

    +2.89%
    884.54

    T

    Therapeuticsmd Inc

    TXMD

    +0.88%
    1.15

    J

    Johnson & Johnson

    JNJ

    -0.23%
    154.58

    A

    Abbvie Inc

    ABBV

    +3.15%
    186.06

    Z

    Zoetis Inc

    ZTS

    +0.77%
    153.47

    G

    Gilead Sciences Inc

    GILD

    -2.81%
    103.17

    N

    Novo-Nordisk A/S

    NVO

    -0.88%
    62.08

    B

    Bristol-Myers Squibb Co

    BMY

    -1.62%
    47.90

    A

    Alexion Pharms

    ALXN

    +1.70%
    182.50

    P

    Pfizer

    PFE

    +0.61%
    22.92

    S

    Sanofi FR

    SNY

    -2.28%
    52.32

    S

    Sanofi FR

    GCVRZ

    0.00%
    0.8711

    N

    Novartis

    NVS

    +0.87%
    112.14

    D

    Dr Reddys Labs

    RDY

    -1.50%
    13.79

    G

    GSK PLC

    GSK

    -0.19%
    37.43
    Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
    During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
    More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
    Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
    Language

    English

    ©2025 Webull Securities Limited. All rights reserved.